daewoong gliatamin cdmo
Scope
Date
~
-
Bio & Pharma
Medytox files complaint with ITC against Hugel over botox strain
South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...
Apr 01, 2022 (Gmt+09:00)
-
Biotech
SK invests $350 mn in US CDMO firm
SK Inc., the holding company of SK Group, announced Sunday that it invested $350 million into Pennsylvania-based Center for Breakthrough Medicines (...
Jan 10, 2022 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco to raise up to $498 mn on $5 bn valuation
SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...
Jan 10, 2022 (Gmt+09:00)
-
Pharamaceuticals
Korea’s CHA Biotech to triple US CDMO capacity
CHA Biotech, South Korea’s stem cell therapeutics developer, is set to expand its biomaterials contract development and manufacturing organiza...
Jan 05, 2022 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language